Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Investigate Something else for Less: Financial plan Travel Objections - 25 Fundamental Ways to employ a Criminal Legal counselor
- 3UAE-backed Yemeni Southern Transitional Council denies disbandment rumors
- 4The Fate of Rest: Patterns in Shrewd Beds
- 5Tributes pour in for James Ransone, 'The Wire' actor who died at 46
- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- The Best Computer games Ever
- The Craft of Computerized Detox: Individual Trials
- What we know about the 'Stranger Things' spinoff — plus the one cast member who guessed it correctly
- 10 Natural products to Remember for Your Eating routine for a Better You
- Is an $85 apple pie worth it? Our Thanksgiving taste test says … maybe.
- 10 Moving Design Frill for Summer 2023
- FDA updates risk classification for voluntary shredded cheese recall
- Mali and Canadian miner Barrick agree to resolve tax dispute, ending 2-year standoff
